Alkali Metal Or Alkaline Earth Metal Patents (Class 424/665)
-
Patent number: 12084601Abstract: A package includes a patch and a packaging film. The patch comprises a support and a sealing layer comprising chlorite ions. The support is permeable to chlorine dioxide. The packaging film has an inner surface defining at least a portion of an interior space of the package for housing an article. The packaging film is substantially impermeable to chlorine dioxide and is transparent to ultraviolet light. The patch is affixed to the inner surface of the packaging film by the sealing layer. Chlorine dioxide may be generated by subjecting the package to ultraviolet (UV) light such that the UV light reaches the sealing layer of the patch to convert the chlorite ions to chlorine dioxide.Type: GrantFiled: December 28, 2017Date of Patent: September 10, 2024Assignee: AMCOR FLEXIBLES NORTH AMERICA, INC.Inventors: Rishabh Jain, Claire E. Kalb
-
Patent number: 11857570Abstract: The present invention relates to a composition based on components of natural origin, in particular ozonized olive oil and liquid vegetable extracts, for the topical treatment of vaginosis and/or vulvovaginitis of bacterial and/or fungal origin.Type: GrantFiled: May 27, 2022Date of Patent: January 2, 2024Assignee: ORGANICARE LLCInventors: Franco Papa, Renato Colognato
-
Patent number: 11801167Abstract: Systems, methods, and apparatuses for generating and releasing iodine are described. Some embodiments may include a dressing member including a plurality of iodine-forming reagents and a water-swellable material. In some embodiments, the dressing member may include water-swellable fibers. The water-swellable fibers may each include a water-swellable material in which iodine-forming reagents are dispersed. As liquid comes into contact with and is absorbed by the water-swellable material, the iodine-forming reagents may come into contact with each other, causing an iodine-forming reaction to occur, producing iodine.Type: GrantFiled: July 16, 2021Date of Patent: October 31, 2023Assignee: KCI Licensing, Inc.Inventors: Timothy Mark Robinson, Brian Andrews, Christopher Brian Locke
-
Patent number: 11523608Abstract: Disclosed are devices, systems, and methods for producing broad spectrum disinfectants, sanitizers, cleaner and deodorizers using chlorine dioxide compositions, and more particularly, to methods for producing chlorine dioxide compositions having improved long term stability by the proper choice of pH and through the careful choice of other product formula ingredients.Type: GrantFiled: May 26, 2020Date of Patent: December 13, 2022Assignee: SPECTRUM DOXYICIDE, LLCInventor: Stephen Bradford Kong
-
Patent number: 11497215Abstract: Disclosed are devices, systems, and methods for producing broad spectrum disinfectants, sanitizers, cleaner and deodorizers using chlorine dioxide compositions, and more particularly, to methods for producing chlorine dioxide compositions having improved long term stability by the proper choice of pH and through the careful choice of other product formula ingredients.Type: GrantFiled: August 17, 2020Date of Patent: November 15, 2022Assignee: SPECTRUM DOXYICIDE, LLCInventor: Stephen Bradford Kong
-
Patent number: 11369682Abstract: A composition comprising an organic photoactivator, a gasotransmitter salt which converts into a gasotransmitter via electron transfer, and an electron donor which donates an electron to the photoactivator when the photoactivator is in a photo-excited state.Type: GrantFiled: April 24, 2019Date of Patent: June 28, 2022Assignee: Noxsano Inc.Inventors: Alan Willey, Stevan Samuel
-
Patent number: 11306404Abstract: The production system of chlorine dioxide solution includes a water storage device, an electrolyte storage device, an electrolytic device, a reaction device, a storage device, a cooling device, and a cleaning device. These devices jointly work together to manufacture chlorine dioxide solution systematically and in mass production.Type: GrantFiled: November 19, 2020Date of Patent: April 19, 2022Inventors: Cheng-Hong Chen, Cheng-Yu Chen
-
Patent number: 10918652Abstract: The present disclosure is directed to topical dermatological formulations, dermatological cleansing compositions, and bathwater conditioners designed to acidify the skin, and their use for restoring epidermal acidity, restoring a the epidermal barrier, inhibiting inflammation, establishing an environment appropriate for maintaining a balanced symbiotic microbiome, and inhibiting the growth of pathogenic microorganisms in the epidermis—the outer layer of mammalian skin.Type: GrantFiled: July 11, 2019Date of Patent: February 16, 2021Assignee: Claridei Laboratories, Inc.Inventor: Cheryl Lee Eberting
-
Patent number: 10485827Abstract: Methods for preparing an eye serum formulation are disclosed. The methods include electrolyzing a saline solution having a salt concentration between about 0.01% and about 1.0% by weight using a voltage between about 0 V and about 30 V across an inert anode and a spaced apart inert cathode to generate a target mixture of chemically reduced and oxidized molecules within the saline solution, mirroring the target mixture of chemically reduced and oxidized species in the electrolyzed saline solution to the reduced species and reactive oxygen species found in a known biological system, adding a rheology modifier, adding a buffering agent, and adding a silicone oil. The target mixture of chemically reduced and oxidized molecules comprises one or more of hypochlorous acid, hypochlorites, dissolved oxygen, chlorine, hydrogen gas, hydrogen peroxide, hydrogen ions, hypochloride, superoxides, ozone, activated hydrogen ions, chloride ions, hydroxides, singlet oxygen, *OCl, and *HO—.Type: GrantFiled: January 18, 2017Date of Patent: November 26, 2019Assignee: RDG HOLDINGS, INC.Inventor: Andrew Hoover
-
Patent number: 10485193Abstract: A method is provided. In this method, a first tray positioned at a first end of a trough assembly at a selected tier is engaged. The first tray is then lifted and removed. A second tray is then engaged and moved vertically to the selected tiers. It is placed in the trough assembly at a second end. Other trays—which are positioned within the trough assembly between the first and second ends of the selected tier—are moved toward the first end of the trough assembly.Type: GrantFiled: May 27, 2016Date of Patent: November 26, 2019Inventors: Robert V. Neuhoff, Jr., Joseph H. Murdler
-
Patent number: 9945584Abstract: The present invention provides an excellent heating tool in which the generation of unpleasant odors is suppressed. The present invention also provides an excellent heating tool in which changes in aroma are suppressed. The present invention further provides an excellent heating tool in which the generation of unpleasant odors and changes in aroma are suppressed even after storage. The present invention provides a method for suppressing the generation of unpleasant odors and changes in aroma in a heating tool. The present invention provides a heating tool comprising an exothermic composition containing a metal ion sequestrant, an oxidizable metal powder, a water-soluble salt, and water, wherein at least the exothermic composition is housed in an air-permeable container bag.Type: GrantFiled: July 29, 2013Date of Patent: April 17, 2018Assignee: Kobayashi Pharmaceutical Co., Ltd.Inventors: Yuki Yasuda, Hiromichi Tanaka, Daisuke Nishioka
-
Patent number: 9204633Abstract: A water based, alcohol-free, skin sanitizing solution with a natural skin softener, where the nature of the biocidal enhancer used in the process of making the solution significantly increases efficacy while simultaneously enabling much more economical manufacturing, processing and transportation of the product. Because it is water based, no further moisturizing additives are required, and those with sensitive skin, diabetes, allergies or religious beliefs are able to use the product without concern.Type: GrantFiled: August 12, 2013Date of Patent: December 8, 2015Assignee: Aphex Biocleanse Systems, Inc.Inventor: David John Weaver
-
Publication number: 20150132409Abstract: Agents and devices for affecting nerve function are described. In some variations, a combination of agents, e.g., a cardiac glycoside, an ACE inhibitor, and an NSAID are delivered to affect nerve function. The agent may be delivered locally in a site-specific manner to a targeted nerve or portion of a nerve. For example, the agent may be delivered locally to the renal nerves to impair their function and treat hypertension. One variation of a delivery device includes one or more needle housings supported by a balloon. A delivery needle is slidably disposed within a needle lumen of each needle housing.Type: ApplicationFiled: May 7, 2013Publication date: May 14, 2015Inventors: Emily A. Stein, Christina D. Swanson, Michael A. Evans, Kondapavulur T. Venkateswara-Rao
-
Publication number: 20150125551Abstract: A method of manufacturing and an apparatus for making an aqueous chlorine solution having a pH between 3.0 and 6.5 and a stability such that after 6 weeks storage at 20 degrees Celsius the pH remains in the range 3.0 to 6.5 and the amount of chlorine lost from the solution is less than 10%, such that the method includes: (a) Providing a source of water having an electrical conductivity at 20 degrees Celsius of no more than 50 (and preferably no more than 4.3) ?Scm-1 (b) Reacting the water with solid calcium hypochlorite having a purity of at least 60%; and (c) Adjusting the pH to between 3.0 and 6.5.Type: ApplicationFiled: October 20, 2014Publication date: May 7, 2015Inventors: Stephen Thomas BOND, Kevin John BYRNE, Simon Joseph WARD, Natasha Ann Crawford PAGE
-
Publication number: 20150118325Abstract: The present invention provides a method for preventing or treating an inflammatory response, condition or disease in a mammal comprising administering an effective amount of a dilute stabilised hypochlorite solution to said mammal in need thereof as well as a means for mixing and administering fresh, dilute stabilised hypochlorite solution to the site where it is needed.Type: ApplicationFiled: October 29, 2014Publication date: April 30, 2015Applicant: Hypo-Stream LimitedInventor: Myles H. E. Dakin
-
Patent number: 9005671Abstract: This invention provides concentrated aqueous biocidal solutions formed from bromine chloride, sodium hydroxide, and sulfamic acid. The weight ratio of bromine chloride:sodium hydroxide:sulfamic acid used in forming the concentrated solution is such that for every 10.5 to 11.5 parts by weight of bromine chloride used, 15.3 to 17.5 parts by weight of sodium hydroxide and 11.0 to 12.5 parts by weight of sulfamic acid are used, the biocidal solution containing at least about 100,000 ppm (wt/wt) of active bromine based on the total weight of the solution.Type: GrantFiled: September 7, 2005Date of Patent: April 14, 2015Assignee: Albemarle CorporationInventor: Farah D. Azarnia
-
Publication number: 20150056303Abstract: The present invention is directed to a method, system and equipment for the elaboration of electrolytic chlorine oxidants, hypochlorous acid and sodium hypochlorite substances, using elements that result in an ecological process and confers a high efficiency in the production of these substances, permitting the generation of a product of very high performance and efficiency.Type: ApplicationFiled: August 23, 2013Publication date: February 26, 2015Inventors: Miguel Angel Alcantara, Adan Tapia Duran
-
Publication number: 20150044301Abstract: A system is disclosed for preparing a hypodermic injection site comprising a visibility enhancer for an injection site and a post injection hypodermic puncture wound site. The present invention offers a number of significant improvements which advance the efficacy of the art, by: preventing unintentional hypodermic injection of medicines through un-sanitized or under-sanitized skin surfaces, thereby protecting patients from becoming inoculated with pathogenic microorganisms while receiving such injections; significantly improving the visibility of, and, the accurate visual location and bandaging of post-injection needle puncture entry wounds, thereby further reducing the risk of infection of such wounds; and, by reducing bleeding from such wounds, which, in turn, reduces healthcare worker exposure to blood-borne pathogens and reduces the generation of potentially infectious, biohazardous medical waste.Type: ApplicationFiled: August 8, 2013Publication date: February 12, 2015Inventor: Hans Werner Bottesch
-
Publication number: 20150037320Abstract: The present invention provides a method of treating a macrophage related disease comprising administering to a subject in need thereof an effective amount of an oxidative agent or an immunosuppressive agent. The present invention also provides a method of modulating macrophage accumulation or activation comprising administering to a subject in need thereof an effective amount of an oxidative agent or an immunosuppressive agent. The oxidative agent can be chlorite or a chlorite containing compound.Type: ApplicationFiled: May 6, 2014Publication date: February 5, 2015Applicants: Neuraltus Pharmaceuticals, Inc., The Regents of the University of CaliforniaInventors: Michael S. McGrath, Arasteh Ari Azhir
-
Patent number: 8940340Abstract: Systems and methods for maintaining the dominance of Nannochloropsis in an algae cultivation system are provided. Exemplary methods include applying an effective amount of a disinfectant to Nannochloropsis growing in an algae cultivation system. Another method for maintaining the dominance of Nannochloropsis in an algae cultivation system includes adjusting a salinity in the algae cultivation system to between approximately 0.5 PPT and 28 PPT. In a further method, the temperature of the algae cultivation system may be adjusted to between approximately 21 and 32 degrees Celsius (“° C.”). According to yet another method for maintaining the dominance of Nannochloropsis in an algae cultivation system, a salinity in the algae cultivation system may be adjusted to below that of seawater for a first predetermined period of time, and then the salinity in the algae cultivation system may be adjusted to a higher salinity for a second predetermined period of time.Type: GrantFiled: January 22, 2009Date of Patent: January 27, 2015Assignee: Aurora Algae, Inc.Inventors: Joseph Weissman, Guido Radaelli
-
Publication number: 20150004254Abstract: An externally-used solution containing chlorine dioxide for promoting hair growth is composed of chlorine dioxide or its precursors, pH regulators, medical solvents and plant extract in a certain weight ratio. The product may take the forms of a single solution containing chlorine dioxide or several solutions containing a chlorine dioxide precursor. The safety and effective oxidation sterilization and tissue regeneration ability of chlorine dioxide are introduced into the solution system for promoting hair growth, and the steps of removing hair loss factors, stimulating the growth of hair follicles, anti-inflammatory and anti-dandruff are done synchronously. Complemented medical solvents and plant extracts will change alopecia environment.Type: ApplicationFiled: September 1, 2012Publication date: January 1, 2015Inventor: Xuewu Liu
-
Publication number: 20150001066Abstract: A wipe for anti-microbial disinfecting includes a flexible substrate and an anti-microbial ion source integrated on the substrate. The flexible substrate is made entirely or in part of woven fiber cloth, non-woven fiber cloth, woven synthetic cloth, non-woven synthetic cloth, or natural fiber cloth. The anti-microbial ion source is configured to dissolve in an aqueous solution to form an anti-microbial solution. The flexible substrate is configured to absorb the anti-microbial solution for use in cleaning.Type: ApplicationFiled: June 25, 2014Publication date: January 1, 2015Inventor: Ashok V. Joshi
-
Publication number: 20140348951Abstract: A dialysis acid precursor assembly including: a dry dialysis acid precursor composition including sodium chloride, a dry acid and a magnesium chloride 4.5-hydrate (MgCl2.4.5H2O), a calcium salt and at least one of a potassium salt, calcium salt and an anhydrous glucose, and a moisture-resistant container having a water vapor transmission rate less than 0.2 g/m2/d at 38° C./90% RH, wherein the dry dialysis acid precursor composition is sealed in the container.Type: ApplicationFiled: December 11, 2012Publication date: November 27, 2014Inventors: Olof Jansson, Jens Gustafsson, Torbjorn Linden
-
Publication number: 20140319059Abstract: Provided herein is a method for reducing down-time in a recreational body of water having a water filtering system and water recirculation system after a potential release of Cryptospridium oocyst and/or Giardia cysts. Also described is a kit for practicing the method for reducing down-time in a recreational body of water that may have a potential release of Cryptospridium oocyst and/or Giardia cysts.Type: ApplicationFiled: April 25, 2014Publication date: October 30, 2014Inventor: Michael Joseph Unhoch
-
Patent number: 8871278Abstract: The present invention provides a stabilized hypohalous acid solution (or formulation thereof), which may be conveniently packaged for sale, or stored for later use on demand. The invention further provides methods of making the stabilized hypohalous acid solution, as well as methods of use for disinfecting mammalian tissue, including wounds and burns, disinfecting or cleansing surfaces, or treating and/or preserving food products and cut flowers, among other uses.Type: GrantFiled: March 19, 2012Date of Patent: October 28, 2014Assignee: Puricore, Inc.Inventors: Svetlana Panicheva, Mark N. Sampson, Vadim Panichev, Gerald N. Dibello, Martyn James Rogers, Ronan Stapleton, Steven Lewis Short
-
Publication number: 20140302107Abstract: The invention provides an aqueous bleaching solution for substrate treatment. The aqueous bleaching solution features a source of oxidant and a plurality of optically functional nanoparticles. The optically functional nanoparticles are nanoparticles in the range of about 0.1 nanometers to about 400 nanometers in size. The aqueous bleaching solution may optionally include one or more an oxidant-stable surfactants and optionally, one or more oxidant-stable polymers, and adjuncts. The optically functional nanoparticles are extremely stable in the aqueous bleaching solution and remain substantially suspended in the aqueous bleaching solution due to their extremely small size despite having an average density greater than that of the bleaching solution.Type: ApplicationFiled: December 13, 2013Publication date: October 9, 2014Applicant: The Clorox CompanyInventors: Gregory VanBuskirk, Scott L. Cumberland, Thomas W. Kaaret, William L. Smith
-
Publication number: 20140287064Abstract: Fungal infections and other disease conditions of the integument can be effectively treated with compositions containing ozonizable oils, plant extract oils and antimicrobials, when used in conjunction with solutions containing sodium chlorite. The compositions are particularly useful for treatment of resistant fungal infections.Type: ApplicationFiled: May 28, 2014Publication date: September 25, 2014Inventor: Karen G. Swenholt
-
Publication number: 20140287065Abstract: Pigs infected with PEDv often die due to dehydration caused by diarrhea. Those that survive do not reach market weight as scheduled resulting in costs to the producer. The invention includes providing electrolyzed water either as treatment for infected animals or as a prophylactic against symptom severity in uninfected animals. The electrolyzed water is used as a substitute for or as a solution with regular drinking water. Duration of symptoms for infected pigs is markedly lessened; severity of symptoms is also reduced providing a much higher survival rate. Time to market is less negatively affected for surviving pigs than those untreated, and weight at scheduled time for sale is also less effected translating into positive financial results over those expected for untreated herds.Type: ApplicationFiled: February 24, 2014Publication date: September 25, 2014Applicant: Ag Odor Control, LLCInventor: Robert D. Watson
-
Publication number: 20140212512Abstract: The invention provides a liquid composition when used for maintenance of a body of water, the liquid composition comprising a solution of magnesium and potassium salts, at least one of which is a halide salt. Preferably, the liquid composition comprises Mg2+ from the magnesium salt in an amount of from about 6000 ppm to about 15 000 ppm; K+ from the potassium salt in an amount from about 40 000 ppm to about 120 000 ppm and hypohalite from the halide in an amount from about 100 000 ppm to about 400 000 ppm.Type: ApplicationFiled: July 10, 2012Publication date: July 31, 2014Applicant: Zodiac Group Australia Pty LtdInventor: Ross Leslie Palmer
-
Publication number: 20140178501Abstract: A method for controlling microbial or biofilm growth in a medium includes mixing ammonium carbamate or ammonium sulfamate with an aqueous solution of a hypochlorite oxidant to form a biocide having a pH between 9.0 and 11.5, the molar ratio of the ammonium carbamate or ammonium sulfamate to the hypochlorite being at least 1:1; and then applying the biocide to the medium.Type: ApplicationFiled: December 11, 2013Publication date: June 26, 2014Inventor: Ayala BARAK
-
Publication number: 20140134278Abstract: The present invention provides a composition containing an aluminate and calcium hypochlorite, wherein the content of the aluminate is 1.0 part by weight to less than 2 parts by weight based on 100 parts by weight of the composition.Type: ApplicationFiled: June 21, 2012Publication date: May 15, 2014Inventors: Toshiyuki Yamashita, Yoshinori Kamatsuchi
-
Patent number: 8709498Abstract: A method of stimulating tissue healing in humans or animals includes administering to a human or animal suffering from lesions and infections linked to chronic and/or acute periodontitis a pharmaceutically effective amount of a pharmaceutical composition including (i) at least one sodium halopohalite, and (ii) at least one N-halogenated taurine, wherein halogens from the (i) at least one sodium halopohalite and from the (ii) at least one N-haloamine taurine, which may be the same or different, are selected from the group consisting of fluorine, iodine, bromine and chlorine.Type: GrantFiled: December 22, 2010Date of Patent: April 29, 2014Inventor: Arnaud Mainnemare
-
Publication number: 20140113007Abstract: Provided is a chlorine dioxide-generating product comprising an inorganic porous carrier carrying a chlorite and an alkali agent. In the product, the alkali agent is carried in an amount of more than 0.7 molar equivalent and not more than 2 molar equivalents relative to the amount of the chlorite carried, and the product has a water content of 10% by weight or less. The chlorine dioxide-generating product can stably generate chlorine dioxide gas in an amount that sufficiently achieves deodorization, sterilization, virus removal, mold prevention, antisepsis, or the like of spatial environments, foods, or others but exerts no harmful effect on humans, over a long period of time.Type: ApplicationFiled: May 30, 2012Publication date: April 24, 2014Applicant: DAISO CO., LTD.Inventors: Ryo Kato, Kanefusa Hara, Masanori Yanagida
-
Patent number: 8691285Abstract: Methods of using a non-irritant, low pH acidic composition to destroy undesirable microorganisms are described. The methods may be used on food products, food processing equipment, and in aqueous solutions.Type: GrantFiled: July 14, 2011Date of Patent: April 8, 2014Assignee: CMS Innovative Technologies, Inc.Inventors: Barry Cummins, David Creasey
-
Patent number: 8691286Abstract: A composition for dissolving or reducing the viscosity of sputum on a surface of a device includes an effective amount of glycerol and an effective amount of dextran sulfate in a saline solution. The effective amount of glycerol is between about 30-50% and the effective amount of dextran sulfate is between about 10-30%. The composition may further include an antimicrobial agent.Type: GrantFiled: January 26, 2010Date of Patent: April 8, 2014Assignee: Teleflex Medical IncorporatedInventors: Nisha Gupta, Erin Peters, Joel Rosenblatt
-
Patent number: 8679548Abstract: Described are highly concentrated liquid biocidal solutions formed in water from (a) specified bromine sources (e.g., BrCl or mixtures of BrCl and Br2) and (b) alkali metal salt of sulfamic acid and/or sulfamic acid and alkali metal base, wherein the solution contains >160,000 ppm of active bromine. Solutions of this type have been found to have greater stability than a commercially-available solution made from the same components containing 148,600 ppm of active bromine. Also described are new, water-soluble, solid state biocidal products formed by removing the water from solutions made in water from (a) and (b) irrespective of the initial concentration of active bromine. Removal of water can be accomplished by flashing or distillation at reduced pressure or preferably by spray drying. Such solid state products are typically in the form of powders or small particles, but can be compacted into larger forms preferably with the aid of one or more suitable binding agents.Type: GrantFiled: March 11, 2013Date of Patent: March 25, 2014Assignee: Albemarle CorporationInventors: Christopher J. Nalepa, Robert M. Moore, Jr.
-
Patent number: 8663705Abstract: An improved method and apparatus for producing a stable, non-toxic, antimicrobial electrolyzed saline solution with a broad range of anti-infective and therapeutic applications. The resulting electrolyzed saline solution exhibits a marked lack of toxicity upon intravenous, aspired, oral or topical application in mammals for therapeutic applications providing a broad platform, including topical disinfection, antimicrobial application, wound treatment, oxidative stress reduction and enhancement of immune function to better detect malfunctioning cells.Type: GrantFiled: December 28, 2012Date of Patent: March 4, 2014Assignee: Reoxcyn Discoveries Group, Inc.Inventors: Verdis Norton, Gary L. Samuelson
-
Patent number: 8632823Abstract: Super-oxidized water based on hypochlorous acid, such as is obtained by the electrochemical treatment of a saline solution, may be used in the treatment of leg ulcers or other open wounds. Preferably, the pH of the super-oxidized water is in a range of 4 to 7, and the water has a redox potential of >950 mV. Medicaments based on the super-oxidized water may be in liquid or gel form. The super-oxidized water is able to control the microbial population within the wound and at the same time permit cell proliferation.Type: GrantFiled: December 21, 2007Date of Patent: January 21, 2014Assignee: Puricore, Inc.Inventor: Joe B. Selkon
-
Publication number: 20130316020Abstract: This application described a wound dressing comprising an absorbent material, an effective amount of chlorite and an amount of a base to provide a pH of the dressing material greater than or equal to about (10). Advantageously, the wound dressings of the present application provide a convenient source of chlorite that is stable and easy to use.Type: ApplicationFiled: February 9, 2012Publication date: November 28, 2013Inventors: Servet Buyuktimkin, Nadir Buyuktimkin, Edward T. Kisak, Dominic King-Smith, John M. Newsam, Jagat Singh
-
Publication number: 20130295022Abstract: The present invention provides a highly tolerable, hydrating lanolin containing foamable composition for administration to the skin, body surface, body cavity or mucosal surface, e.g., the mucosa of the nose, mouth, eye, ear, respiratory system, vagina or rectum. The foamable composition includes lanolin, a surface-active agent, about 0.01% to about 5% by weight of at least one polymeric additive selected from the group consisting of a bioadhesive agent, a gelling agent, a film forming agent and a phase change agent, water, and a liquefied or compressed gas propellant at a concentration of about 3% to about 25% by weight of the total composition.Type: ApplicationFiled: June 6, 2013Publication date: November 7, 2013Inventors: Doron Friedman, Alex Besonov, Dov Tamarkin, Meir Eini
-
Patent number: 8568759Abstract: The present invention provides an environmentally compatible, pesticidal composition and method for the control of insect pests. The composition includes two components. The first component is a chelating agent, a metal complex of a chelating agent, and mixtures thereof, and the second component is preferably a carrier material.Type: GrantFiled: December 14, 2010Date of Patent: October 29, 2013Assignee: W. Neudorff GmbH KGInventor: Diana L. Parker
-
Patent number: 8563019Abstract: Disclosed is a method of making a non-aqueous chlorine dioxide solution by combining a chlorite salt and a non-aqueous carboxylic acid and the non-aqueous chlorine dioxide solution made by this method. Also disclosed are methods of disinfecting an object by applying the non-aqueous chlorine dioxide solution to the object and methods of disinfecting a liquid by adding the non-aqueous chlorine dioxide solution to the liquid.Type: GrantFiled: March 19, 2009Date of Patent: October 22, 2013Assignee: Diversey, Inc.Inventor: Michael F. Coughlin
-
Patent number: 8541034Abstract: New electrical producing creams are provided. In one embodiment, the electrical producing creams comprise menthol and camphor, preferably provided as part of a base gel, supplemented with potassium and a source of oxygen. The most preferred base gel is sold under the name SOMBRA. In another embodiment, the electrical producing creams comprise potassium and a source of oxygen supplemented with optional active and inactive ingredients. The most preferred source of oxygen is a chlorite (e.g., sodium chlorite) and/or spirulina. The electrical producing creams provide high metabolic activities and sustain those activities over prolonged periods of time, thus being useful for treating a large variety of ailments, including diabetic neuropathy, post hepatic neuralgia, scleroderma, psoriasis, strain, spasticity, headaches, neuropathy secondary to drugs, peripheral neuropathy, leg pain, muscle cramps, muscle aches and pains, bruise, sinusitis, sprain, arthritis, joint pain (arthralgia), and edema.Type: GrantFiled: October 3, 2007Date of Patent: September 24, 2013Inventor: Clyde E. Morgan
-
Patent number: 8507011Abstract: A composition and method are described for suppressing or preventing fibrous adhesion formation using a multicomponent aqueous oxychlorine composition. Fibrous adhesions typically form during healing of tissue, for example following a surgical procedure. A multicomponent oxychlorine composition is provided for irrigating the tissue which minimizes post-surgical adhesion formation, the composition containing both chlorine dioxide and chlorite ion, and a complexion thereof. The chlorine dioxide level generally is in an effective range of ClO2 concentration from about 10 ppm to a maximum of about 110 ppm. In a preferred embodiment, a physiological composition is provided in a thickened form to increase retention in the area being treated.Type: GrantFiled: March 19, 2010Date of Patent: August 13, 2013Inventors: Robert D. Kross, Cleva Villanueva
-
Patent number: 8501244Abstract: Described herein are chlorite formulations having a pH between about 7 and about 8.5, wherein the chlorite formulations are substantially free of deleterious non-chlorite components. Described herein are chlorite formulations, including pharmaceutical formulations, which are formulated for systemic, parenteral, or intravenous administration. Described herein are methods of preparing and methods of using the chlorite formulations described herein.Type: GrantFiled: September 29, 2011Date of Patent: August 6, 2013Assignee: Neuraltus Pharmaceuticals, Inc.Inventors: William Boulanger, Arasteh Ari Azhir
-
Patent number: 8455010Abstract: A balanced redox-signaling compound with reactive molecules that mimic those naturally occurring inside cells that have been precisely stabilized and formulated as a supplement for oral consumption acting to enhance proper immune system function, enhance the efficiency and production of the body's native antioxidants as well as enhance the performance of intercellular communications involved in healthy tissue maintenance and athletic performance.Type: GrantFiled: November 24, 2009Date of Patent: June 4, 2013Assignee: Reoxcyn Discoveries Group, IncInventors: Verdis Norton, Gary L. Samuelson
-
Patent number: 8449899Abstract: Disclosed is a method of making a non-aqueous chlorine dioxide solution by combining a chlorite salt and a non-aqueous carboxylic acid and the non-aqueous chlorine dioxide solution made by this method. Also disclosed are methods of disinfecting an object by applying the non-aqueous chlorine dioxide solution to the object and methods of disinfecting a liquid by adding the non-aqueous chlorine dioxide solution to the liquid.Type: GrantFiled: March 19, 2009Date of Patent: May 28, 2013Assignee: Diversey, Inc.Inventor: Michael F. Coughlin
-
Publication number: 20130101683Abstract: The invention is directed to compositions and methods of their use as effective biocidal agents for water streams. The composition comprises a halogen source, halogen stabilizers containing a sulfur bearing species and ammonium salts/urea, and an alkali. The sulfur bearing species includes sulfamic acid or its salt equivalent. By having optimized mixing ratio of halogen to stabilizer and that of ammonium salts to sulfamic acid or sulfamate, a synergistic effect occurs which both increases the efficacy of the composition as a biocide and it avoids adverse impacts on other chemicals that are present in the water stream. Best of all the composition is easy to form and easy to introduce into a water stream of concern. Its introduction can be as simple as mixing two containers of reagent prior to introduction to the water process stream.Type: ApplicationFiled: November 4, 2011Publication date: April 25, 2013Applicant: NALCO COMPANYInventors: Wen Li TU, Laura E. RICE, Andrew J. COOPER, Elisa M. LUTH, Yu-mei LU, Jian Kun SHEN
-
Publication number: 20130101682Abstract: A composition and methods of its use, the composition comprising: a halogen source, urea, and an additional halogen stabilizer excluding urea, optionally an alkali in a concentration sufficient to provide said composition with a pH of greater than 10; and optionally excluding a stabilized bromine compound from said composition is disclosed. Additionally, a method for reducing biological activity in a process stream is disclosed. The method comprises: providing a composition to a process stream, wherein said composition contains: a halogen, urea, and an additional halogen stabilizer excluding urea, optionally an alkali in a concentration sufficient to provide said composition with a pH of greater than 10; and optionally excluding a stabilized bromine compound from said composition. The invention is also directed to compositions and methods of their use as effective biocidal agents for water streams.Type: ApplicationFiled: November 4, 2011Publication date: April 25, 2013Applicant: NALCO COMPANYInventors: Laura E. RICE, Andrew J. COOPER, Elisa M. LUTH, Wen Li TU
-
Patent number: 8414932Abstract: Described are highly concentrated liquid biocidal solutions formed in water from (a) specified bromine sources (e.g., BrCl or mixtures of BrCl and Br2) and (b) alkali metal salt of sulfamic acid and/or sulfamic acid and alkali metal base, wherein the solution contains >160,000 ppm of active bromine. Solutions of this type have been found to have greater stability than a commercially-available solution made from the same components containing 148,600 ppm of active bromine. Also described are new, water-soluble, solid state biocidal products formed by removing the water from solutions made in water from (a) and (b) irrespective of the initial concentration of active bromine. Removal of water can be accomplished by flashing or distillation at reduced pressure or preferably by spray drying. Such solid state products are typically in the form of powders or small particles, but can be compacted into larger forms preferably with the aid of one or more suitable binding agents.Type: GrantFiled: October 28, 2002Date of Patent: April 9, 2013Assignee: Albemarie CorporationInventors: Christopher J. Nalepa, Robert M. Moore, Jr.